Avanir Pharmaceuticals is cutting 73 employees in “sales-related positions,” or roughly 11 percent of its workforce, according to a recent filing with California state officials. A spokesman confirmed the move and described it as an effort to “streamline our current approach to sales and better position Avanir to pursue its long-term mission.”
The layoffs occur as that mission is coming under scrutiny.
About the Author Reprints
